Madrigal Pharmaceuticals, Inc. - MDGL

Include option trades

Include indirect trades

Latest data: 4/7/2025 10:19:14 PM

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

Total $0

No buy transactions for this time period.

Sell Breakdown

Total $5,442,630

Monthly Totals

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
03/10/2025 10b5-1	03/12/2025	Dier Mardi SVP and CFO CFO	Sell	-258 @ $323.04	($83,344.32)	10,440	(-2.41%)	Direct
03/03/2025 10b5-1	03/05/2025	Dier Mardi SVP and CFO CFO	Sell	-1,961 @ $324.96	($637,248.06)	6,914	(-22.10%)	Direct
03/03/2025 10b5-1	03/05/2025	Huntsman Carole Chief Commercial Officer Officer	Sell	-1,834 @ $325.98	($597,839.68)	8,604	(-17.57%)	Direct
03/03/2025 10b5-1	03/05/2025	Kelley Shannon T General Counsel Officer	Sell	-415 @ $335.00	($139,025.00)	7,290	(-5.39%)	Direct
02/28/2025	03/04/2025	Waltermire Robert E. Senior VP, Chief Pharma Dev. Officer	Sell	-1,227 @ $341.07	($418,488.05)	3,728	(-24.76%)	Direct
01/24/2025	01/27/2025	Huntsman Carole Chief Commercial Officer Officer	Sell	-347 @ $335.24	($116,328.28)	10,438	(-3.22%)	Direct
01/24/2025	01/27/2025	Sibold William John President and CEO CEO Director	Sell	-1,584 @ $335.24	($531,020.16)	54,303	(-2.83%)	Direct
01/24/2025	01/27/2025	Taub Rebecca Pres., R&D, and CMO Officer Director	Sell	-648 @ $335.24	($217,235.52)	456,662	(-0.14%)	Direct
01/24/2025	01/27/2025	Waltermire Robert E. Senior VP, Chief Pharma Dev. Officer	Sell	-103 @ $335.24	($34,529.72)	4,955	(-2.04%)	Direct
01/17/2025	01/17/2025	Kelley Shannon T General Counsel Officer	Sell	-277 @ $273.41	($75,734.57)	7,705	(-3.47%)	Direct
01/17/2025	01/17/2025	Taub Rebecca Pres., R&D, and CMO Officer Director	Sell	-1,689 @ $273.41	($461,789.49)	457,310	(-0.37%)	Direct
01/17/2025	01/17/2025	Waltermire Robert E. Senior VP, Chief Pharma Dev. Officer	Sell	-442 @ $273.41	($120,847.22)	5,058	(-8.04%)	Direct
11/21/2024	11/22/2024	Huntsman Carole Chief Commercial Officer Officer	Sell	-688 @ $316.92	($218,040.96)	10,785	(-6.00%)	Direct
09/09/2024	09/11/2024	Sibold William John President and CEO CEO Director	Sell	-6,363 @ $243.83	($1,551,490.29)	55,887	(-10.22%)	Direct
05/21/2024	05/23/2024	Waltermire Robert E. Senior VP, Chief Pharma Dev. Officer	Sell	-1,036 @ $231.34	($239,668.24)	5,500	(-15.85%)	Direct